BRNS

Barinthus Biotherapeutics
BRNS

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $58.3M invested in Barinthus Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$28.6M
2
+$6.01M
3
+$3.1M
4
MIM
Monashee Investment Management
Massachusetts
+$2.22M
5
Millennium Management
Millennium Management
New York
+$2.18M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$28.6M
2
$10.8M
3
$6.01M
4
$3.1M
5
$2.22M
6
$2.18M
7
$839K
8
$839K
9
$726K
10
$671K
11
$515K
12
$420K
13
$420K
14
$284K
15
$194K
16
$168K
17
$168K
18
$145K
19
$18.5K